4.7 Article

99m-Radiolabeled Silica Nanocarriers for Targeted Detection and Treatment of HER2-Positive Breast Cancer

Related references

Note: Only part of the references are listed.
Review Cell Biology

Breast cancer diagnosis: Imaging techniques and biochemical markers

Seyed Hamed Jafari et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2018)

Article Chemistry, Physical

Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity

Benedetta Riva et al.

JOURNAL OF COLLOID AND INTERFACE SCIENCE (2018)

Review Cell Biology

Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma

Chang-Yu Chen et al.

JOURNAL OF BIOMEDICAL SCIENCE (2018)

Article Nanoscience & Nanotechnology

Development of 99mTc- radiolabeled nanosilica for targeted detection of HER2-positive breast cancer

Paolo Rainone et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)

Article Oncology

Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women

Carol E. DeSantis et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

Article Multidisciplinary Sciences

Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies

Miriam Colombo et al.

NATURE COMMUNICATIONS (2016)

Article Oncology

Cancer Statistics, 2015

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

A novel multivalent 99mTc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts

Chongjiao Li et al.

NUCLEAR MEDICINE AND BIOLOGY (2015)

Article Biochemical Research Methods

FunRich: An open access standalone functional enrichment and interaction network analysis tool

Mohashin Pathan et al.

PROTEOMICS (2015)

Review Chemistry, Multidisciplinary

Nanomaterials for Theranostics: Recent Advances and Future Challenges

Eun-Kyung Lim et al.

CHEMICAL REVIEWS (2015)

Review Oncology

Trastuzumab emtansine: mechanisms of action and drug resistance

Mark Barok et al.

BREAST CANCER RESEARCH (2014)

Review Oncology

HER2 testing: Current status and future directions

Edith A. Perez et al.

CANCER TREATMENT REVIEWS (2014)

Review Oncology

Unique Features of Young Age Breast Cancer and Its Management

Han-Byoel Lee et al.

JOURNAL OF BREAST CANCER (2014)

Article Medicine, Research & Experimental

Taxonomy of breast cancer based on normal cell phenotype predicts outcome

Sandro Santagata et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Review Chemistry, Multidisciplinary

Overview of nano-drugs characteristics for clinical application: the journey from the entry to the exit point

Tanima Bose et al.

JOURNAL OF NANOPARTICLE RESEARCH (2014)

Review Chemistry, Multidisciplinary

Molecular imaging of breast cancer: present and future directions

David Alcantara et al.

FRONTIERS IN CHEMISTRY (2014)

Article Oncology

The current state of breast cancer classification

G. Viale

ANNALS OF ONCOLOGY (2012)

Article Multidisciplinary Sciences

Comprehensive molecular portraits of human breast tumours

Daniel C. Koboldt et al.

NATURE (2012)

Article Oncology

Proteomic profiling of lipid rafts in a human breast cancer model of tumorigenic progression

Joseph A. Caruso et al.

CLINICAL & EXPERIMENTAL METASTASIS (2011)

Article Biochemistry & Molecular Biology

Gata-3 Negatively Regulates the Tumor-Initiating Capacity of Mammary Luminal Progenitor Cells and Targets the Putative Tumor Suppressor Caspase-14

Marie-Liesse Asselin-Labat et al.

MOLECULAR AND CELLULAR BIOLOGY (2011)

Review Biochemical Research Methods

Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation

Hak Soo Choi et al.

MOLECULAR IMAGING (2010)

Article Biochemical Research Methods

Semi-supervised learning for peptide identification from shotgun proteomics datasets

Lukas Kall et al.

NATURE METHODS (2007)

Article Multidisciplinary Sciences

Patterns of somatic mutation in human cancer genomes

Christopher Greenman et al.

NATURE (2007)

Article Medicine, General & Internal

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

DJ Slamon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Chemistry, Multidisciplinary

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

H Maeda et al.

JOURNAL OF CONTROLLED RELEASE (2000)